<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="ijerph-17-05904-t002" orientation="portrait" position="float">
 <object-id pub-id-type="pii">ijerph-17-05904-t002_Table 2</object-id>
 <label>Table 2</label>
 <caption>
  <p>Clinical symptoms integrated with the severity of COVID-19 [
   <xref rid="B48-ijerph-17-05904" ref-type="bibr">48</xref>,
   <xref rid="B66-ijerph-17-05904" ref-type="bibr">66</xref>].
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Clinical Type</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Symptoms</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Mild disease</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">No signs of pneumonia; it happened in 81% of patients.</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Severe disease</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Oxygen saturation of blood ≤93%, infiltration of lungs ≥50% within one or two days. The ratio of PaO2/FiO2 (oxygen partial pressure/fraction of inspired oxygen) &lt;300. GGO (ground glass opacities): 14% of cases acquired severe symptoms.</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Critical disease</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Failure of the respiratory system, septic shock, concerted organ dysfunction, or multiple organ failure (MOF); it happened in 5% of patients.</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
